Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
MONDAY, Dec. 23, 2024 -- For women aged 40 to 49 years, there are considerable disparities and gaps in biennial mammography screening, according to a research letter published online Dec. 20 in JAMA Network Open.
Tianshu Gu, M.D., from the University of Tennessee Health Science Center in Memphis, and colleagues examined disparities and gaps in breast cancer screening among women aged 40 to 49 years using nationally representative data from the National Health Interview Survey in 2019 and 2021. Mammography screening was self-reported and classified into biennial screening, overdue screening, and no screening.
The researchers found that of the 20.1 million women, 11.7, 3.0, and 5.0 million (weighted percentage, 59.2, 15.2, and 25.6 percent, respectively) reported biennial, overdue, and no screening, respectively. Among several minority groups, the biennial screening rates were significantly lower: non-Hispanic women with other race, lesbian and bisexual women, rural residents, and those with a family income at 138 percent or less of the federal poverty level (FPL). As family income decreased, the rate of biennial screening decreased. The likelihood of overdue screening versus biennial screening was increased in association with lacking a usual place of care (risk difference, 0.07). Factors associated with a higher probability of no screening included being non-Hispanic Asian, having family income based on FPL, being uninsured, and lacking a usual place for care.
"Targeted interventions and policies aimed at enhancing health care access, coverage, and affordability hold significant potential to improve health equity in biennial mammography screening for women aged 40 to 49 years," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.